Skip to main content
logo
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
87.67
+0.14 (0.15%)
Nov 3, 2026, 1:53 PM EST - Market open

BioNTech SE Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
1,289105.6118.1907.41,519260.8182.81,1901,245128.7187.61,479895.3167.71,2774,2783,4613,1976,3755,533
Revenue Growth (YoY)
-15.12%-59.51%-35.39%-23.75%22.02%102.64%-2.56%-19.54%39.04%-23.26%-85.31%-65.43%-74.13%-94.75%-79.97%-22.67%-43.14%-39.78%211.20%1501.77%
Cost of Revenue
103.39771.4302.8148.376.483.8243.5178.959.859.1179.1161.8162.996183.5752.8764.61,294583.2
Gross Profit
1,1868.646.7604.61,371184.499946.51,06668.9128.51,300733.54.81,1814,0952,7082,4325,0814,949
Selling, General & Admin
178.5197.8150.8217.9148.5137.4120.6132.1150.5183.8132.6142.3153.5137.9124134.5153.8147.8105.1148.8
Research & Development
748.1477.1557505.4564.8509.1525.6611.8550.3584.6507.5577.8497.9373.4334509.8341.8399.6285.8271.5
Other Operating Expenses
134.3185.519.9183.9690.3-31.9-11.944.1344.2262.3-8.5-425.729.7-17.3-55.5-208.1274.4191.960.9149.6
Operating Expenses
1,061860.4727.7907.21,404614.6634.37881,0451,031631.6294.4681.1494402.5436.2770739.3451.8569.9
Operating Income
125-851.8-681-302.6-33-430.2-535.3158.520.9-961.8-503.11,00652.4-489.2778.53,6591,9381,6934,6294,379
Interest Expense
-8.3-3.5-4--2.6-3.7-3.7-2.1-5.3-4.8-4.7-3.4-2-1.3-1.2-2.1-4.3-5.8-4.1-3.4
Interest & Investment Income
-66.461.7265.5-68.977437.6-------38.87.71.50.50.3
Currency Exchange Gain (Loss)
--12.613.44.4-20.5-41.4-39.835.228.114.822.3-487.633.9-45.4-144.3-519.7502.3631178.8196.9
Other Non Operating Income (Expenses)
105.323.842.1-173.896.833.641.4-298.4156.2167.7174.9162.2148.5126.682.3---214.21.3
EBT Excluding Unusual Items
222-777.7-567.8-206.540.7-372.8-460.4330.8199.9-784.1-310.6676.7232.8-409.3715.33,1762,4442,3195,0184,575
Gain (Loss) on Sale of Investments
---0.33.1--6.5--------------
Asset Writedown
--73.9--30.5----------------
Legal Settlements
--7.1--8.5-16-23.4--29.6-41.2-21.7-21.2-13.5-5.4-2.9-7.6-3----
Other Unusual Items
---15--15------------139.4
Pretax Income
222-858.7-568.1-227.424.7-402.7-445.4301.2158.7-805.8-331.8663.2227.4-412.2707.73,1732,4442,3195,0184,714
Income Tax Expense
37.5-37.9-36.277.653.4-16.1-29.641.7-39.42-16.7205.366.8-221.8205.5893.9659.2647.31,3191,548
Earnings From Continuing Operations
184.5-820.8-531.9-305-28.7-386.6-415.8259.5198.1-807.8-315.1457.9160.6-190.4502.22,2791,7851,6723,6993,166
Net Income
184.5-820.8-531.9-305-28.7-386.6-415.8259.5198.1-807.8-315.1457.9160.6-190.4502.22,2791,7851,6723,6993,166
Net Income to Common
184.5-820.8-531.9-305-28.7-386.6-415.8259.5198.1-807.8-315.1457.9160.6-190.4502.22,2791,7851,6723,6993,166
Net Income Growth (YoY)
--------43.33%23.35%---79.91%-91.00%--86.42%-28.03%-44.41%-40.01%227.88%762.96%
Shares Outstanding (Basic)
249253253244239242240240242240241240240241243243240244244244
Shares Outstanding (Diluted)
253253253244239242240240245240241241243241245246256259260260
Shares Change (YoY)
5.67%4.85%5.38%1.55%-2.21%0.50%-0.08%-0.30%0.51%-0.25%-1.81%-2.06%-4.84%-7.03%-5.69%-5.34%-1.65%0.17%1.08%-11.96%
EPS (Basic)
0.74-3.24-2.10-1.25-0.12-1.60-1.731.080.82-3.36-1.311.910.67-0.792.079.387.436.8615.1312.96
EPS (Diluted)
0.73-3.24-2.10-1.25-0.12-1.60-1.731.080.81-3.36-1.311.900.66-0.792.059.266.986.4514.2412.18
EPS Growth (YoY)
--------43.20%22.73%---79.52%-90.54%--85.60%-23.94%-43.48%-40.11%224.37%880.76%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-163.4-44.1-477.8246.3744.8119.4-829.6-529.9-711.71,539-375.8767.2757.24,320-722.6692.64,7013,8494,006-238.9
Free Cash Flow Per Share
-0.65-0.17-1.891.013.110.49-3.45-2.21-2.916.40-1.563.183.1117.92-2.952.8118.3814.8515.42-0.92
Gross Margin
91.99%8.14%39.54%66.63%90.24%70.71%54.16%79.54%85.63%53.53%68.50%87.89%81.93%2.86%92.48%95.71%78.25%76.08%79.70%89.46%
Operating Margin
9.70%-806.63%-576.63%-33.35%-2.17%-164.95%-292.83%13.32%1.68%-747.32%-268.18%67.98%5.85%-291.71%60.96%85.52%56.00%52.95%72.61%79.16%
Profit Margin
14.31%-777.27%-450.38%-33.61%-1.89%-148.24%-227.46%21.81%15.91%-627.66%-167.96%30.96%17.94%-113.54%39.33%53.26%51.57%52.31%58.02%57.23%
Free Cash Flow Margin
-12.68%-41.76%-404.57%27.14%49.04%45.78%-453.83%-44.53%-57.17%1195.49%-200.32%51.87%84.58%2575.73%-56.59%16.19%135.82%120.40%62.84%-4.32%
EBITDA
457.3-585.7-559.7-266.9591.2-379.2-492.5278.365.3-911.9-464.81,03993.7-457.3809.93,6751,9721,7264,6564,391
EBITDA Margin
35.47%---29.42%6.00%-145.40%-269.42%23.39%5.25%--247.76%70.26%10.47%-272.69%63.42%85.89%56.97%53.99%73.05%79.37%
D&A For EBITDA
332.3266.1121.335.65124.25142.8119.844.449.938.333.641.331.931.416.1333.533.227.611.55
EBIT
125-851.8-681-302.6-33-430.2-535.3158.520.9-961.8-503.11,00652.4-489.2778.53,6591,9381,6934,6294,379
EBIT Margin
9.70%---33.35%-2.17%-164.95%-292.83%13.32%1.68%--268.18%67.98%5.85%-291.71%60.96%85.52%56.00%52.95%72.61%79.16%
Effective Tax Rate
16.89%---216.19%--13.84%---30.96%29.38%-29.04%28.18%26.97%27.91%26.29%32.83%
Revenue as Reported
---------------4,2783,4613,1976,3755,533
SEC Filings: 10-K · 10-Q